Suspended NA INTERVENTIONAL 2-arm NCT04743076

A Randomized Trial Of Endovascular Treatment For Acute Posterior Large Vessel Occlusion (BASILAR-2)

Standard Medical Treatment Plus Endovascular Treatment Versus Standard Medical Treatment Alone for Stroke Patient With Large Vessel Occlusion In The Posterior Circulation: A Multicenter, Randomized, Clinical Trial

Sponsor: Xinqiao Hospital of Chongqing

Conditions Vertebrobasilar Stroke

Interventions Endovascular treatment Standard medical treatment

Updated 6 times since 2021 Last updated: Sep 7, 2021 Started: Mar 16, 2021 Primary completion: May 16, 2024 Completion: May 16, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

Withdrawal of funding

A NA clinical study on Vertebrobasilar Stroke, this trial is suspended. The trial is conducted by Xinqiao Hospital of Chongqing and has accumulated 6 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Suspended NA
Sep 2024 — Sep 2025 [monthly]

Suspended NA
Jul 2024 — Sep 2024 [monthly]

Suspended NA
Oct 2021 — Jul 2024 [monthly]

Suspended NA

Status: Recruiting → Suspended
Apr 2021 — Oct 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Mar 2021 — Apr 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xinqiao Hospital of Chongqing

Data source: Xinqiao Hospital of Chongqing

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Banan, China , Changchun, China , Chongqing, China , Guilin, China , Hefei, China , Jiangmen, China , Longquan, China , Luzhou, China , Maoming, China , Nanyang, China and 5 more locations